TSC2 and acute myeloid leukemia: In addition, the developmental mechanisms giving raise to AML lesions has remained elusive4,15, contributing to the lack of success in previous attempts to ablate TSC1 or TSC2 by means of tissue-specific Cre-mediated recombination16,17.